首页>
外国专利>
MOLECULAR DISSECTION OF CELLULAR RESPONSES TO ALLOANTIGEN OR AUTOANTIGEN IN GRAFT REJECTION AND AUTOIMMUNE DISEASE
MOLECULAR DISSECTION OF CELLULAR RESPONSES TO ALLOANTIGEN OR AUTOANTIGEN IN GRAFT REJECTION AND AUTOIMMUNE DISEASE
展开▼
机译:移植排斥反应中细胞对同种异体抗原或自体抗原的分子解剖及自发性疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
An antigen-specific T-ceII response to alloantigen, tissue-specific antigen (e.g., islet antigen or other autoantigens involved in autoimmune disease), or self (or host) antigen is detected at an early stage of graft rejection or recurrent autoimmunity. An increase in cytotoxic lymphocyte gene (CLG) expression in peripheral blood is a risk factor for development of deleterious immune responses, which may be confirmed by functional assays. For example, the distinction between production of regulatory or inflammatory cytokines by T cells may dissect the type of immune response which is being induced: the survival of transplanted islet cells used to treat type 1 diabetes may be monitored, loss of the transplant by graft rejection (i.e., an alloantigen target) may be distinguished from autoimmune disease (i.e., a self or host antigen target).
展开▼